The Makers of the Omnipod® Insulin Management System

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® System platform. The Omnipod® System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days* of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives.

Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it already does in the United States and Canada. European customers can find additional information about our transition at and can also register for email updates. For information about the current distribution of the Omnipod® Insulin Management System in Europe and support before July 1, 2018, please visit mylife_OmniPod.

The Makers of the Omnipod® System


Learn more about Insulet Corporation, an innovative medical device company based outside of Boston, MA.

 Visit our investor site


Our team is committed to making a difference in the lives of people with diabetes.

 Search our openings

Delivery Systems

Partner with Insulet Delivery Systems Group to deliver the full potential of your drug via the Pod.

 Learn more


Our Podder™ Community welcomes people with diabetes from around the world.

 Visit one of our international websites

Media and Investor Inquiries

We would be happy to talk to your further. Please contact us via mail, phone, or email:

Insulet Corporation
600 Technology Park Drive, Suite 200
Billerica, MA 01821

Corporate telephone: 978-600-7000
Corporate fax: 978-600-0120
From outside the US: 978-600-7850
Confidential customer fax: 877-467-8538
Customer Care: 800-591-3455

Investor inquiries email:
Media inquiries email:

*Up to 72 hours of insulin delivery